Sarah Cannon, Tennesse Oncology — Nashville, Tennessee

Sarah Cannon, Tennesse Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon, Tennesse Oncology has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Cancer.

Sponsors: Jazz Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon, Tennesse Oncology?

Sarah Cannon, Tennesse Oncology has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon, Tennesse Oncology conducted?

Sarah Cannon, Tennesse Oncology has 1 clinical trials on record. Their work covers Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Cancer.

Is Sarah Cannon, Tennesse Oncology accredited by Crixeo Health?

Sarah Cannon, Tennesse Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon, Tennesse Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.